| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Freeman Kevin D is a Director at GALECTIN THERAPEUTICS INC. Recent SEC Form 4 filings include 9 buys and 0 sells.
Estimated insider holdings value: $116K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 15, 2019 | GALT Galectin Therapeutics Inc | Director | Buy | 3,000 | $3.36 | $10,075.80 | +27.3% | |
| Sep 6, 2019 | GALT Galectin Therapeutics Inc | Director | Buy | 1,290 | $3.71 | $4,785.90 | +13.3% | |
| May 31, 2019 | GALT Galectin Therapeutics Inc | Director | Buy | 9,136 | $4.28 | $39,102.08 | +38.0% | |
| Apr 5, 2019 | GALT Galectin Therapeutics Inc | Director | Buy | 500 | $4.73 | $2,365.00 | +33.3% | |
| Feb 8, 2019 | GALT Galectin Therapeutics Inc | Director | Buy | 1,500 | $4.29 | $6,427.50 | New | |
| Feb 1, 2018 | GALT Galectin Therapeutics Inc | Director | Buy | 2,000 | $4.10 | $8,191.00 | +14.3% | |
| Feb 1, 2018 | GALT Galectin Therapeutics Inc | Director | Buy | 2,000 | $4.10 | $8,191.00 | +14.3% | |
| Jun 1, 2015 | GALT Galectin Therapeutics Inc | Director | Buy | 2,083 | $2.70 | $5,624.10 | New |